Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1969 Mar;28(2):157–162. doi: 10.1136/ard.28.2.157

Indomethacin in the treatment of rheumatoid arthritis. A controlled trial comparing indomethacin, phenylbutazone, and placebo.

V Wright, W C Walker, R J McGuire
PMCID: PMC1031124  PMID: 4887768

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOLAND E. W. NONSPECIFIC ANTI-INFLAMMATORY AGENTS. SOME NOTES ON THEIR PRACTICAL APPLICATION, ESPECIALLY IN RHEUMATIC DISORDERS. Calif Med. 1964 Mar;100:145–155. [PMC free article] [PubMed] [Google Scholar]
  2. Bonhomme F. Détermination du pouvoir arthrogène chez le rat d'une fraction peptido-glyco-lipidique de cire D administrée sous forme d'adjuvant de type Freund. Sem Hop. 1967 Apr 8;43(17):1134–1137. [PubMed] [Google Scholar]
  3. COSTA G., ASTALDI G. EFFETTO DELLA DAUNOMICINA SULL'ATTIVIT'A PROLIFERATIVA DI CELLULE STAMINALI OTTENUTE IN COLTURA DA SANGUE UMANO NORMALE. Tumori. 1964 Nov-Dec;50:477–480. doi: 10.1177/030089166405000606. [DOI] [PubMed] [Google Scholar]
  4. Currey H. L., Ziff M. Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet. 1966 Oct 22;2(7469):889–891. doi: 10.1016/s0140-6736(66)91984-2. [DOI] [PubMed] [Google Scholar]
  5. DIMARCO A., SOLDATI M., FIORETTI A., DASDIA T. RICERCHE SULL'ATTIVITA' DELLA DAUNOMICINA SU CELLULE NORMALI E NEOPLASTICHE COLTIVATE IN VITRO. Tumori. 1963 Jul-Aug;49:235–251. [PubMed] [Google Scholar]
  6. DUBOST M., GANTER P., MARAL R., NINET L., PINNERT S., PREUDHOMME J., WERNER G. H. UN NOUVEL ANTIBIOTIQUE 'A PROPRI'ET'ES CYTOSTATIQUES: LA RUBIDOMYCINE. C R Hebd Seances Acad Sci. 1963 Sep 9;257:1813–1815. [PubMed] [Google Scholar]
  7. Donnelly P., Lloyd K., Campbell H. Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects. Br Med J. 1967 Jan 14;1(5532):69–75. doi: 10.1136/bmj.1.5532.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Emmerson B. T. Regimen of indomethacin therapy in acute gouty arthritis. Br Med J. 1967 Apr 29;2(5547):272–274. doi: 10.1136/bmj.2.5547.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gery I., Waksman B. H. Studies of the mechanism whereby adjuvant disease is suppressed in rats pretreated with mycobacteria. Int Arch Allergy Appl Immunol. 1967;31(1):57–68. doi: 10.1159/000229854. [DOI] [PubMed] [Google Scholar]
  10. Glenn E. M. Adjuvant-induced arthritis: effects of certain drugs on incidence, clinical severity, and biochemical changes. Am J Vet Res. 1966 Jan;27(116):339–352. [PubMed] [Google Scholar]
  11. Glenn E. M., Gray J., Kooyers W. Chemical changes in adjuvant-induced polyarthritis of rats. Am J Vet Res. 1965 Sep;26(114):1195–1203. [PubMed] [Google Scholar]
  12. HART F. D., BOARDMAN P. L. INDOMETHACIN: A NEW NON-STEROID ANTI-INFLAMMATORY AGENT. Br Med J. 1963 Oct 19;2(5363):965–970. doi: 10.1136/bmj.2.5363.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Healey L. A. An appraisal of indomethacin. Bull Rheum Dis. 1967 Dec;18(4):483–486. [PubMed] [Google Scholar]
  14. Jessop J. D., Currey H. L. Influence of gold salts on adjuvant arthritis in the rat. Ann Rheum Dis. 1968 Nov;27(6):577–581. doi: 10.1136/ard.27.6.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KALLIOMAEKI J. L., SAARIMAA H. A., TOIVANEN P. INHIBITION BY 6-MERCAPTOPURINE OF POLYARTHRITIS INDUCED BY FREUND'S ADJUVANT. Ann Rheum Dis. 1964 Jan;23:78–80. doi: 10.1136/ard.23.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KELLY M. INDOMETHACIN, REMARKABLE ANTIRHEUMATIC DRUG. Med J Aust. 1964 Oct 3;2:541–544. doi: 10.5694/j.1326-5377.1964.tb109467.x. [DOI] [PubMed] [Google Scholar]
  17. Kapusta M. A., Mendelson J. Inhibition of adjuvant arthritis by statolon. Proc Soc Exp Biol Med. 1967 Nov;126(2):496–499. doi: 10.3181/00379727-126-32487. [DOI] [PubMed] [Google Scholar]
  18. Kourilsky F. M., Dupuy J. M., Fradelizi D., Jacquillat C., Bernard J. Abolition des réactions d'hypersensibilité retardée et gravité des aplasies induites par la rubidomycine. Pathol Biol. 1967 Oct;15(19):959–959. [PubMed] [Google Scholar]
  19. LANSBURY J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations. Arthritis Rheum. 1958 Dec;1(6):505–522. doi: 10.1002/art.1780010604. [DOI] [PubMed] [Google Scholar]
  20. LIDDLE L., SEEGMILLER J. E., LASTER L. The enzymatic spectrophotometric method for determination of uric acid. J Lab Clin Med. 1959 Dec;54:903–913. [PubMed] [Google Scholar]
  21. LOWE J. S. SERUM PROTEIN CHANGES IN RATS WITH ARTHRITIS INDUCED BY MYCOBACTERIAL ADJUVANT. Biochem Pharmacol. 1964 Apr;13:633–641. doi: 10.1016/0006-2952(64)90050-4. [DOI] [PubMed] [Google Scholar]
  22. MUELLER M. N., KAPPAS A. ESTROGEN PHARMACOLOGY. II. SUPPRESSION OF EXPERIMENTAL IMMUNE POLYARTHRITIS. Proc Soc Exp Biol Med. 1964 Dec;117:845–847. doi: 10.3181/00379727-117-29715. [DOI] [PubMed] [Google Scholar]
  23. Malpas J. S., Scott R. B. Rubidomycin in acute leukaemia in adults. Br Med J. 1968 Jul 27;3(5612):227–229. doi: 10.1136/bmj.3.5612.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mathé G., Hayat M., Schwarzenberg L., Amiel J. L., Schneider M., Cattan A., Schlumberger J. R., Jasmin C. Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms. Lancet. 1967 Aug 19;2(7512):380–382. doi: 10.1016/s0140-6736(67)92004-1. [DOI] [PubMed] [Google Scholar]
  25. NEWBOULD B. B. CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT. Br J Pharmacol Chemother. 1963 Aug;21:127–136. doi: 10.1111/j.1476-5381.1963.tb01508.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. PERCY J. S., STEPHENSON P., THOMPSON M. INDOMETHACIN IN THE TREATMENT OF RHEUMATIC DISEASES. Ann Rheum Dis. 1964 May;23:226–231. doi: 10.1136/ard.23.3.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pinals R. S., Frank S. Relative efficacy of indomethacin and acetylsalicylic acid in rheumatoid arthritis. N Engl J Med. 1967 Mar 2;276(9):512–514. doi: 10.1056/NEJM196703022760906. [DOI] [PubMed] [Google Scholar]
  28. Pitkeathly D. A., Banerjee N. R., Harris R., Sharp J. Indomethacin in in-patient treatment of rheumatoid arthritis. Ann Rheum Dis. 1966 Jul;25(4):334–339. doi: 10.1136/ard.25.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Quagliata F., Sanders P. M., Gardner D. L. Inhibition of rat adjuvant arthritis by a new immunosuppressive agent rubidomycin. Experientia. 1968 Oct 15;24(10):1028–1029. doi: 10.1007/BF02138727. [DOI] [PubMed] [Google Scholar]
  30. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  31. Smyth C. J. Indomethacin in rheumatoid arthritis. A comparative objective evaluation with adrenocorticosteroids. Arthritis Rheum. 1965 Oct;8(5):921–942. doi: 10.1002/art.1780080503. [DOI] [PubMed] [Google Scholar]
  32. Tan C., Tasaka H., Yu K. P., Murphy M. L., Karnofsky D. A. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer. 1967 Mar;20(3):333–353. doi: 10.1002/1097-0142(1967)20:3<333::aid-cncr2820200302>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  33. Thompson M., Percy J. S. Further experience with indomethacin in the treatment of rheumatic disorders. Br Med J. 1966 Jan 8;1(5479):80–83. doi: 10.1136/bmj.1.5479.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. WAKSMAN B. H., WENNERSTEN C. PASSIVE TRANSFER OF ADJUVANT ARTHRITIS IN RATS WITH LIVING LYMPHOID CELLS OF SENSITIZED DONORS. Int Arch Allergy Appl Immunol. 1963;23:129–139. doi: 10.1159/000229412. [DOI] [PubMed] [Google Scholar]
  35. WANKA J., DIXON A. S. TREATMENT OF OSTEO-ARTHRITIS OF THE HIP WITH INDOMETHACIN. A CONTROLLED CLINICAL TRIAL. Ann Rheum Dis. 1964 Jul;23:288–294. doi: 10.1136/ard.23.4.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. WANKA J., JONES L. I., WOOD P. H., DIXON A. S. INDOMETHACIN IN RHEUMATIC DISEASES. A CONTROLLED CLINICAL TRIAL. Ann Rheum Dis. 1964 May;23:218–225. doi: 10.1136/ard.23.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. WARD J. R., CLOUD R. S., KRAWITT E. L., JONES R. S. STUDIES ON ADJUVANT-INDUCED POLYARTHRITIS IN RATS. 3. THE EFFECT OF "IMMUNOSUPPRESSIVE AGENTS" ON ARTHRITIS AND TUBERCULIN HYPERSENSITIVITY. Arthritis Rheum. 1964 Dec;7:654–661. doi: 10.1002/art.1780070605. [DOI] [PubMed] [Google Scholar]
  38. Ward J. R., Cloud R. S. Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats. J Pharmacol Exp Ther. 1966 Apr;152(1):116–121. [PubMed] [Google Scholar]
  39. Winter C. A., Nuss G. W. Treatment of adjuvant arthritis in rats with anti-inflammatory drugs. Arthritis Rheum. 1966 Jun;9(3):394–404. doi: 10.1002/art.1780090304. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES